Not to be too cynical, but how many deaths did Pfizer expect?
Deaths Halt Development Of Pfizer Cholesterol Drug - WSJ.com
Pfizer Inc. halted development of a drug to boost good cholesterol that was the most important medicine in its pipeline, after more patients than expected died during a large clinical test.The unanticipated deaths became known Saturday after a board of independent experts reviewed the latest data from a 15,000-patient test of the drug called torcetrapib.
Half the people in the study, which was supposed to last three more years, took a combination of torcetrapib and Lipitor. The other half took only Lipitor.
Tags: Pharmaceuticals
